ID: ALA5195172

Max Phase: Preclinical

Molecular Formula: C20H19F3N2O3S

Molecular Weight: 424.44

Associated Items:

Representations

Canonical SMILES:  Cn1c(=O)c(C(CCCOC(=O)c2cccs2)CC(F)(F)F)nc2ccccc21

Standard InChI:  InChI=1S/C20H19F3N2O3S/c1-25-15-8-3-2-7-14(15)24-17(18(25)26)13(12-20(21,22)23)6-4-10-28-19(27)16-9-5-11-29-16/h2-3,5,7-9,11,13H,4,6,10,12H2,1H3

Standard InChI Key:  BAPXJOIJVSSSED-UHFFFAOYSA-N

Associated Targets(non-human)

Pyricularia grisea 1253 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 424.44Molecular Weight (Monoisotopic): 424.1068AlogP: 4.67#Rotatable Bonds: 7
Polar Surface Area: 61.19Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.75CX LogP: 4.83CX LogD: 4.83
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.41Np Likeness Score: -1.06

References

1. Jiang X, Wu K, Bai R, Zhang P, Zhang Y..  (2022)  Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.,  229  [PMID:34998058] [10.1016/j.ejmech.2021.114085]

Source